弥合分歧：从胰腺癌护理中的通用基因检测指南到现实世界中的实施。

IF 4.7 3区医学 Q1 ONCOLOGY

JCO oncology practice Pub Date : 2024-08-01 Epub Date: 2024-05-08 DOI:10.1200/OP.24.00237

Harshabad Singh, Ryan D Nipp

{"title":"弥合分歧：从胰腺癌护理中的通用基因检测指南到现实世界中的实施。","authors":"Harshabad Singh, Ryan D Nipp","doi":"10.1200/OP.24.00237","DOIUrl":null,"url":null,"abstract":"In this editorial accompanying manuscript the by Klatte and colleagues, Drs Singh, and Nipp review the data behind universal germline testing in pancreatic adenocarcinoma, and review possible reasons for and solutions continued inadequate rates of germline testing in our community. Making germline testing for all patients with pancreatic adenocarcinoma is critical and will require cross-disciplinary collaboration and innovation.","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bridging the Divide: From Universal Germline Testing Guidance to Real-World Implementation in Pancreatic Cancer Care.\",\"authors\":\"Harshabad Singh, Ryan D Nipp\",\"doi\":\"10.1200/OP.24.00237\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In this editorial accompanying manuscript the by Klatte and colleagues, Drs Singh, and Nipp review the data behind universal germline testing in pancreatic adenocarcinoma, and review possible reasons for and solutions continued inadequate rates of germline testing in our community. Making germline testing for all patients with pancreatic adenocarcinoma is critical and will require cross-disciplinary collaboration and innovation.\",\"PeriodicalId\":14612,\"journal\":{\"name\":\"JCO oncology practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JCO oncology practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1200/OP.24.00237\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP.24.00237","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

在 Klatte 及其同事、Singh 医生和 Nipp 医生的这篇社论随稿中，他们回顾了胰腺腺癌种系检测普及背后的数据，并探讨了我们社区种系检测率持续不足的可能原因和解决方案。对所有胰腺腺癌患者进行种系检测至关重要，这需要跨学科合作和创新。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Bridging the Divide: From Universal Germline Testing Guidance to Real-World Implementation in Pancreatic Cancer Care.

In this editorial accompanying manuscript the by Klatte and colleagues, Drs Singh, and Nipp review the data behind universal germline testing in pancreatic adenocarcinoma, and review possible reasons for and solutions continued inadequate rates of germline testing in our community. Making germline testing for all patients with pancreatic adenocarcinoma is critical and will require cross-disciplinary collaboration and innovation.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

JCO oncology practice ONCOLOGY-

CiteScore

6.40

自引率

7.50%

发文量

518